SYNLOGIC, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
SYNLOGIC, INC. (SYBX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-12
- SYNLOGIC, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $0.00.
- SYNLOGIC, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2017 was $1.89M, a 220.30% increase from fiscal 2016.
- SYNLOGIC, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2016 was $591.00K, a 10.59% decline from fiscal 2015.
- SYNLOGIC, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2015 was $661.00K, a 71.24% increase from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2017-12-31 | $1.89M 10-K · filed 2018-03-20 | |
| 2016-12-31 | $591.00K 10-K · filed 2018-03-20 | $572.00K 10-K · filed 2017-03-15 |
| 2015-12-31 | $661.00K 10-K · filed 2017-03-15 | |
| 2014-12-31 | $386.00K 10-K · filed 2017-03-15 | |
| 2013-12-31 | $32.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |